| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.077 | 0.09 |